Concord Biotech Profit & Loss Annual

Trade
BSE: 543960 | NSE: CONCORDBIO | ISIN: INE338H01029 | Sector: -
2,073.30 +41.75 (2.06%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,016.94853.17712.93616.94
Total Revenue 1,016.94853.17712.93616.94
Costof Revenue Total 334.17277.86235.66151.42
Gross Profit 682.77575.31477.28465.52
Selling/ General/ Admin Expenses Total 243.19225.17199.13132.42
Depreciation/ Amortization 53.5954.0350.0527.52
Unusual Expense( Income) 0.000.03--
Other Operating Expenses Total 7.944.974.503.34
Total Operating Expense 638.90562.07489.33314.70
Operating Income 378.04291.10223.60302.24
Interest Inc( Exp) Net- Non- Op Total 244.64164.9772.5492.09
Gain( Loss)on Saleof Assets 0.12-0.94-0.340.00
Other Net 10.0514.516.691.27
Net Income Before Taxes 412.57322.01237.52312.72
Provisionfor Income Taxes 104.4681.9362.5977.83
Net Income After Taxes 308.10240.09174.93234.89
Net Income Before Extra Items 308.10240.09174.93234.89
Net Income 308.10240.09174.93234.89
Income Availableto Com Excl Extra Ord 308.10240.09174.93234.89
Income Availableto Com Incl Extra Ord 308.10240.09174.93234.89
Diluted Net Income 308.10240.09174.93234.89
Diluted Weighted Average Shares 10.4610.4610.4610.46
Diluted EPS Excluding Extra Ord Items 29.4522.9516.7222.45
DPS- Common Stock Primary Issue 8.75---
Diluted Normalized EPS 29.4522.9616.7222.45
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts